Good morning, and thank you. Robert Sullivan will follow me with some more details on the results. Consolidated gross margin ...

RBC Capital calls Revolution Medicines (RVMD) a top cancer drug stock, citing strong efficacy and huge growth potential for its lead candidate, daraxonrasib. Read more here.

Fintel reports that on October 30, 2025, RBC Capital Markets reiterated coverage of HSBC Holdings plc - Depositary Receipt ...

Canada’s self-directed investing market is undergoing a sweeping transition as brokerage firms move away from traditional ...

Investing.com - RBC Capital has raised its price target on Dover Corp. (NYSE:DOV) to $198.00 from $183.00 while maintaining a Sector Perform rating. The industrial conglomerate, with a market ...

Fintel reports that on October 24, 2025, RBC Capital maintained coverage of Visteon (NasdaqGS:VC) with a Outperform recommendation. Analyst Price Forecast Suggests 24.32% Upside As of September 30, ...

RBC Capital analyst Leonid Timashev maintained a Buy rating on Alkermes today and set a price target of $47.00. The company’s shares opened today at $30.00. Take advantage of TipRanks Premium at 50% ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Herbert covers the Industrials sector, ...

Investing.com - Jazz Pharmaceuticals (NASDAQ:JAZZ) stock rose after RBC Capital reiterated an Outperform rating with a $151.00 price target following a settlement with Avadel Pharmaceuticals over ...

Investing.com -- RBC Capital Markets began coverage on Caterpillar, Deere and United Rentals. The brokerage initiated Caterpillar at Sector Perform with a $560 price target, saying the heavy equipment ...

Royal Bank of Canada is sharpening its focus on the US wealth management market, with chief executive officer Dave McKay signaling a willingness to pursue acquisitions of established firms as part of ...